Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 1089 questions Show Answers
To ask the Scottish Government what discussions it has had with ScotRail, in light of the company reportedly receiving record fines for its performance in the last financial year.
To ask the Scottish Government how much match funding was made available through the 2017-18 round of Pillar 2 common agricultural policy payments and what proportion was taken up, broken down by Pillar 2 scheme.
To ask the Scottish Government what assessment it has carried out of the impact each year on the (a) rural economy and (b) agricultural sector of the reported problems with the IT system that it introduced to process common agricultural policy basic payments.
To ask the Scottish Government whether it will implement a loan scheme for the 2018-19 round of common agricultural policy basic payments.
To ask the Scottish Government what action it is taking to prevent NHS boards from having to rely on charitable donations to purchase equipment.
To ask the Scottish Government on which dates since 2007 it has announced a revised target completion date for the Aberdeen Western Peripheral Route (AWPR), and what the reason was for each revision.
To ask the Scottish Government what its response is to reports of NHS boards being dependent on charitable donations to help meet funding commitments.
To ask the Scottish Government what assessment it has carried out of the impact of the reported delay in the rollout of ScotRail's planned (a) new and (b) refurbished rolling stock to (i) the rail network and (ii) passengers.
To ask the Scottish Government, in light of reports that the enzyme, PETase, might help reduce plastic pollution, whether it will (a) carry out an assessment of its effectiveness and (b) provide support for (i) additional research and (ii) establishing a safe procedure for its use.